Why NNOX Stock And CEMI Stock Are Skyrocketing Today

Chembio Diagnostics Inc CEMI shares are trading higher by 41% in Monday’s pre-market session after the company announced the commercial launch of a test to differentiate between COVID-19 and the Flu.

Chembio develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis and Zika virus.

See also: Best Investment Apps

Nano-X Imaging Ltd NNOX shares are trading higher by 59% after the company announced on Friday its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the FDA.

Nano-X engages in developing and producing X-ray source technology for the medical imaging industry in the United States. Its X-ray source is based on a novel digital microelectromechanical system semiconductor cathode...Read More

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!